ELIXIR-UK

ELIXIR-UK
Name	ELIXIR-UK
Formation	2014
Headquarters	Cambridge
Leader title	Director
Parent organisation	ELIXIR

ELIXIR-UK ELIXIR-UK is the United Kingdom national node of the pan-European ELIXIR research infrastructure, coordinating bioinformatics resources, data stewardship, and computational services for the life sciences. It connects institutions across England, Scotland, Wales, and Northern Ireland with European initiatives in genomics, proteomics, and biodiversity, supporting projects associated with Wellcome Trust, European Molecular Biology Laboratory, European Bioinformatics Institute, Cancer Research UK, and Medical Research Council. ELIXIR-UK collaborates with major research universities such as University of Cambridge, University of Oxford, Imperial College London, University College London, and University of Edinburgh.

Overview

ELIXIR-UK operates as a national node within the European infrastructure ELIXIR, integrating data resources like UniProt, Ensembl, ArrayExpress, PRIDE (database), and European Nucleotide Archive with compute platforms including European Grid Infrastructure, EMBL-EBI Embassy Cloud, and national high-performance computing centers such as ARCHER (supercomputer). It engages stakeholders from funding bodies including Biotechnology and Biological Sciences Research Council, National Institute for Health and Care Research, and philanthropic organizations like Gordon and Betty Moore Foundation and Bill & Melinda Gates Foundation. ELIXIR-UK supports community efforts coordinated by societies such as the Royal Society, Biochemical Society, Genetics Society, and Society for Experimental Biology.

History and Establishment

ELIXIR-UK was established following the formation of ELIXIR as a response to pan-European data challenges highlighted in reports by European Commission initiatives and panels including those associated with Horizon 2020 and the European Strategy Forum on Research Infrastructures. Key milestones involved partnerships with national institutions such as European Bioinformatics Institute and project consortia funded by Wellcome Trust and BBSRC. Founding collaborators included research groups from University of Manchester, University of Glasgow, University of Warwick, University of Leeds, and industrial partners like GlaxoSmithKline and AstraZeneca.

Governance and Organisation

ELIXIR-UK is governed through a consortium model bringing together representatives from academic institutions, research institutes, and funders such as Wellcome Trust, BBSRC, and Cancer Research UK. Its advisory structures include scientific boards with members drawn from EMBL-EBI, Sanger Institute, Nuffield Department of Medicine, and policy stakeholders from UK Research and Innovation. Operational coordination involves collaborations with infrastructure providers including Janet (network), UK Research IT Directors networks, and cloud partners such as Amazon Web Services and Microsoft Azure via consortia agreements with companies like Dell Technologies and Hewlett Packard Enterprise.

Services and Infrastructure

ELIXIR-UK contributes to service provision in data deposition, metadata standards, and interoperability through platforms such as FAIRsharing, BioStudies, and community tools like Galaxy (platform), Nextflow, and Snakemake. It supports standards development in coordination with organisations such as Global Alliance for Genomics and Health, Committee on Publication Ethics, and the International Nucleotide Sequence Database Collaboration. Infrastructure activities integrate compute resources including EPCC, DiRAC (supercomputing), and cloud resources used by consortia such as 100,000 Genomes Project, UK Biobank, Personal Genome Project UK, and biodiversity initiatives like National Biodiversity Network.

Research and Training Activities

ELIXIR-UK runs training and capacity-building programs partnering with training centers like Carpentries, Bioinformatics Training Partnership, and academic departments at University of Cambridge Department of Genetics, University of Oxford Department of Biology, University College London Research Department of Genetics. It supports workshops tied to initiatives such as European Life-Science Infrastructure for Biological Information conferences, hackathons associated with Open Data Institute, and doctoral training collaborations with graduate schools including Oxford Graduate School and Cambridge Bioinformatics PhD programme. Research collaborations involve projects with Cancer Research UK Cambridge Institute, Francis Crick Institute, Roslin Institute, and clinical collaborations with NHS Digital and Public Health England (now UK Health Security Agency).

Funding and Partnerships

Funding for ELIXIR-UK is drawn from national funders including Wellcome Trust, Biotechnology and Biological Sciences Research Council, Medical Research Council, and university contributions from University of Cambridge, University of Oxford, and University of Edinburgh. Strategic partnerships extend to commercial partners such as Illumina, Thermo Fisher Scientific, GlaxoSmithKline, and AstraZeneca, and to European collaborators like EMBL-EBI, ELIXIR-France, ELIXIR-NL, ELIXIR-Sweden, and ELIXIR-Italy. Participation in EU framework programmes like Horizon Europe and legacy Horizon 2020 projects has been integral to joint calls with infrastructures such as European Open Science Cloud and consortia including CORBEL.

Impact and Contributions to Life Sciences

ELIXIR-UK has contributed to reproducible research, data sharing, and standards adoption impacting projects such as 100,000 Genomes Project, UK Biobank, Genomics England, COVID-19 Genomics UK Consortium, and biodiversity efforts like iNaturalist UK and National Biodiversity Network Atlas. Outputs include training materials used by Bioinformatics Open Source Projects and software cited in publications from institutions like Wellcome Sanger Institute, Francis Crick Institute, and European Molecular Biology Laboratory. Its role in enabling translational research links to clinical and pharmaceutical partners including NHS England, National Institute for Health Research, GlaxoSmithKline, and AstraZeneca.

Category:Bioinformatics Category:Research organisations in the United Kingdom